Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997

European Journal of Pediatrics

Volumn 158, Issue 1, 1999, Pages 46-54

  Burgard, P ^a   Bremer, H J ^b   Buhrdel P ^c   Clemens, P C ^d   Monch E ^e   Przyrembel, H ^f   Trefz, F K ^g   Ullrich, K ^h  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d Klinikum Schwerin   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f Bundesinstitut Gesundheitlichen V   (Germany)

^g Kreiskrankhs Reutlingen Kinderklin   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Hyperphenylalaninaemia; Phenylalanine levels; Phenylketonuria; Treatment recommendations

Indexed keywords

PHENYLALANINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COGNITIVE DEFECT; CONTROLLED STUDY; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; ENZYME DEFICIENCY; HUMAN; HYPERPHENYLALANINEMIA; INFANT; INTELLIGENCE QUOTIENT; MENTAL DEFICIENCY; NEWBORN; PHENYLKETONURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPEECH DEVELOPMENT;

ADOLESCENT; ADULT; EDUCATIONAL MEASUREMENT; ELECTROENCEPHALOGRAPHY; GENETIC SCREENING; GERMANY; HUMANS; INTELLIGENCE TESTS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PHENYLALANINE; PHENYLKETONURIAS; PRACTICE GUIDELINES; SPEECH; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033003339     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051008     Document Type: Article

References (91)

1. Abadie V, Rey F, Plainguet F, Rey J (1992) Evolution intellectuelle après relâchement du régime à lâge de 5 ans dans la phénylcétonurie typique. Arch Fr Pediatr 49:773-778
2. Azen C, Koch R, Friedman E, Wenz E, Fishler K (1996) Summary of findings from the United States Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155 [Suppl 1]:S29-S32
3. Beasley MG, Costello PM, Smith I (1994) Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971. Q J Med 87:155-160
4. Bick U, Fahrendorf G, Ludolph AC, Vassallo P, Weglage J, Ullrich K (1991) Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging. Eur J Pediatr 150:185-189
5. Bick U, Ullrich K, Stöber U, Möller H, Schuierer G, Ludolph AC, Oberwitter C, Weglage J, Wendel U (1993) White matter abnormalities in patients with treated hyperphenylalaninemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 152:1012-1020
6. Brunner RL, Berry HK (1987) Phenylketonuria and sustained attention: the Continuous Performance Test. Int J Clin Neuropsychol 9:68-70
7. Brunner RL, Jordan MK, Berry HK (1983) Early-treated phenylketonuria: neuropsychologic consequences. J Pediatr 102:831-835
8. Brunner RL, Berch DB, Berry H ( 1987) Phenylketonuria and complex spatial visualization: an analysis of information processing. Dev Med Child Neurol 29:460-468
9. Burgard P, Armbruster M, Schmidt E, Rupp A (1994) Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria. Acta Paediatr 83 [Suppl 407]:108-110
10. Burgard P, Rey F, Rupp A, Abadie V, Rey J (1997) Neuropsychological functions of early treated patients with phenylketonuria on and off diet. Results of a cross-national and cross-sectional study. Pediatr Res 41:368-374
11. Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German collaborative study of children treated for phenylketonuria. Eur J Pediatr 155 [Suppl 1]:S33-S38
12. Clarke JTR, Gates RD, Hogan SE, Barrett M, MacDonald GW (1987) Neuropsychological studies in adolescents with phenylketonuria returned to phenylalanine-restricted diets. Am J Ment Retard 92 (3):255-262
13. Cleary MA, Walter JH, Jenkins JPR, Alani SM, Tyler K, Whittle D (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344:87-90
14. Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JPR (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127 (2):251-255
15. Costello PM, Beasley MG, Tillotson SL, Smith I (1994) Intelligence in mild atypical phenylketonuria. Eur J Pediatr 153:260-263
16. Diamond A (1994) Phenylalanine levels of 6-10 mg/dl may not be as benign as once thought. Acta Paediatr 83 [Suppl 407]:89-91
17. Diamond A, Prevor MB, Callendar G, Druin DP (1997). Prefrontal cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 62 (4):1-208
18. Faust D, Libon D, Pueschel S (1986) Neuropsychological functioning in treated phenylketonuria. Int J Psychiatr Med 16:169-177
19. Fisch RO, Chang P-N, Weisberg S, Guldberg P, Güttler F, Tsai MY (1995) Phenylketonuric patients decades after diet. J Inherit Metab Dis 18:347-353
20. Griffiths P, Paterson L, Harvie A (1995) Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria. J Intellect Disabil Res 39 (5):365-372
21. Güttler F, Oleson ES, Wamberg E (1969) Inverse diurnal variation of serum phenylalanine and tyrosine in phenylketonuric children on low-phenylalanine diet. In: Allan JD, Holt KS, Ireland JT, Pollitt, RJ (eds) Enzymopenic anaemias, lysosomes and other papers. Proceedings of the Sixth Symposium of the Society for the Study of Inborn Errors of Metabolism. Livingstone, Edinburgh, pp 149-158
22. Hanley WB, Linsao L, Davidson W, Moes CAF(1970) Malnutrition with early treatment of phenylketonuria. Pediatr Res 4:318-327
23. Harper M, Reid AH (1987) Use of restricted protein diet in the treatment of behavior disorder in a severely mentally retarded adult female phenylketonuric patient. J Ment Defic Res 31:209-212
24. Harvey EL, Kirk SF (1995) The use of a low phenylalanine diet in response to the challenging behaviour of a man with untreated phenylketonuria and profound learning disabilities. J Intellect Disabil Res 39:520-526
25. Hasselbalch S, Knudsen GM, Toft PB, Hogh P, Tedeschi E, Holm S, Videbaek C, Henriksen O, Lou HC, Paulson OB (1996) Cerebral glucose metabolism is decreased in white matter changes in patients with phenylketonuria. Pediatr Res 40:21-24
26. Hopkins A (1995) Some reservations about clinical guidelines. Arch Dis Child 72:70-75
27. Hoskin RG, Sasitharan T, Howard R (1992) The use of a low phenylalanine diet with amino acid supplement in the treatment of behavioral problems in a severely mentally retarded adult female with phenylketonuria. J Intellect Dis Res 36:183-191
28. Huttenlocher P (1979) Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res 163:195-205
29. Jordan MK, Brunner RL, Hunt MM, Berry HK (1985) Preliminary results for the oral administration of valine isoleucine and leucine for Phenylketonuria. Dev Med Child Neurol 27:33-39
30. Knudsen GM, Hasselbalch S, Toft PB, Christensen E, Paulson OB, Lou H (1995) Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J Inherit Metab Dis 18:653-664
31. Koch R, Azen CG, Hurst N, Friedman EG, Fishier K (1987) The effects of diet discontinuation in children with phenylketonuria. Eur J Pediatr 146 [Suppl 1]:A12-A16
32. Krause W, Halminski M, McDonald L, Dembure Ph, Salvo R, Freides D, Elsas L (1985) Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. J Clin Invest 75:40-48
33. Lichter-Konecki U, Rupp A, Konecki DS, Trefz FK, Schmidt H, Burgard P (1994) Relation between phenylalanine hydroxylase genotypes and phenotypic parameters of diagnosis and treatment of hyperphenylalaninemic disorders. J Inherit Metab Dis 17:362-365
34. Lou HC, Güttler F, Lykkelund C, Bruhn P, Niederwieser A (1985) Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 144:17-20
35. Lou HC, Lykkelund C, Gerdes A-M, Udesen H, Bruhn P (1987) Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr Scand 76:560-565
36. Lou HC, Toft PB, Andresen J, Mikkelsen I, Olsen B, Güttler F, Wieslander S, Henriksen O (1992) An occipitio-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia. J Inherit Metab Dis 15:687-695
37. Ludolph AC, Ullrich K, Nedjat S, Masur H, Bick U (1992) Neurological outcome in 22 treated adolescents with hyperphenylalaninemia. Acta Neurol Scand 85:243-248
38. Ludolph AC, Vetter U, Ullrich K (1996) Studies of multimodal evoked potentials in treated phenylketonuria: the pattern of vulnerability. Eur J Pediatr 155 [Suppl 1]:S64-S68
39. MacDonald A, Rylance G, Hall SK, Asplin D, Booth IW (1996) Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch Dis Child 74:412-417
40. Marholin D, Pohl RE, Stewart RM, Touchette PE, Townsend NM, Kolodny EH (1978) Effects of diet and behavior therapy on social and motor behavior of retarded phenylketonuric adults: an experimental analysis. Pediatr Res 12:179-187
41. Mazzocco MM, Yannicelli S, Nord AM, Doorninck W van, Davidson-Mundt AJ, Greene C, Pennington BF (1992) Cognition and tyrosine supplementation among school-age children with phenylketonuria. Pediatric forum. Am J Dis Child 146:1261-1264
42. Medical Research Council Working Party on Phenylketonuria (1993) Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. BMJ 306:115-119
43. Medical Research Council Working Party on Phenylketonuria (1993) Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68:426-427
44. Melnick CR, Michals KK, Matalon R (1981) Linguistic development of children with phenylketonuria and normal intelligence. J Pediatr 98 (2):269-272
45. Möller HE, Vermathen P, Ullrich K, Weglage J, Koch H-G, Peters PE (1995) In-vivo NMR spectroscopy in patients with phenylketonuria: Changes of cerebral phenylalanine levels under dietary treatment. Neuropediatrics 26:199-202
46. Möller HE, Weglage J, Wiederman D, Ullrich K (in press) Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. J Cereb Blood Flow Metab, 1998, 18:1184-1191
47. Okano Y, Eisensmith RC, Güttler F, Lichter-Konecki U, Konecki DS, Trefz FK, Dasovich M, Wang T, Henriksen K, Lou H, Woo SLC (1991) Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 324:1232-1238
48. Ozanne AE, Krimmer H, Murdoch BE (1990) Speech and language skills in children with early treated phenylketonuria. Am J Ment Retard 94:625-632
49. Paans AMJ, Pruim J, Smit GPA, Visser G, Willemsen ATM, Ullrich K (1996) Neurotransmitter PET-studies in adults with phenylketonuria a pilot study. Eur J Pediatr 155 [Suppl 1] S78-S81
50. Pennington BF, Doorninck J van, McCabe LL, McCabe ERB (1985) Neuropsychological deficits in early treated phenylketonuric children. Am J Ment Defic 89 (5):467-474
51. Phenylketonuria: an interdisciplinary survey of management over 40 years (1996) Eur J Pediatr 155 [Suppl 1]:
52. Pietz J, Benninger Ch, Schmidt H, Scheffner D, Bickel H (1988) Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early. Eur J Pediatr 147:361-67
53. Pietz J, Schmidt E, Matthis P, Kobialka B, Kutscha A, Sonneville L de (1993) EEGs in Phenylketonuria I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs and cognitive function. Dev Med Child Neurol 35:54-64
54. Pietz J, Kreis R, Boesch C, Penzien J, Rating D, Herschkowitz N (1995) The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic-resonance spectroscopy. Pediatr Res 38:657-663
55. Pietz J, Kreis R, Schmidt H, Meyding-Lamade UK, Rupp A, Boesch C (1996) Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 201:413-420
56. Pietz J, Meyding-Lamadé UK, Schmidt H (1996) Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Eur J Pediatr 155 [Suppl 1]:S69-S73
57. Pietz J, Fätkenheuer B, Burgard P, Armbruster M, Esser G, Schmidt H (1997) Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics 99:345-350
58. Pitt D (1971) The natural history of untreated phenylketonuria. Med J Aust 58:378-383
59. Pitt DB, Danks DM (1991) The natural history of untreated phenylketonuria over 20 years. J Paediatr Child Health 27:189-190
60. Rey F, Abadie V, Plainguet F, Rey J (1996) Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. Eur J Pediatr 155 [Suppl 1]:S39-S44
61. Rupp A, Burgard P (1995) Comparison of different indices of dietary control in phenylketonuria. Acta Paediatr 84:521-527
62. Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, Sonneville L de (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16:681-688
63. Schmidt E, Burgard P, Rupp A (1996) Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria (PKU). Eur J Pediatr 155 [Suppl 1]:S82-S186
64. Schmidt H, Burgard P, Pietz J, Rupp A (1996) Intelligence and professional career in young adults treated early for phenylketonuria. Eur J Pediatr 155 [Suppl 1]:S97-S100
65. Schwarz HP, Plüss C, Triaca H, Schütz B, Kaufmann R, Scherz R, Bachmann C, Zuppinger K (1988) Verlauf bei 20 Patienten mit frühentdeckter Phenylketonurie und Hyperphenylalaninämie. Schweiz Med Wschr 118:94-99
66. Seashore MR, Friedman E, Novelly RA, Bapat V (1985) Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction. Pediatr 75:226-232
67. Smith I (1985) The hyperphenylalaninemias In: Lloyd JK Scriver CR (eds) Genetic and metabolic disease in pediatrics. Butterworth, London, pp 166-209
68. Smith I, Beasley M (1989) Intelligence and behavior in children with early treated phenylketonuria. Eur J Clin Nutr 43:1-5
69. Smith I, Beasley MG, Wolff OH, Ades AE (1988) Behavior disturbances in 8-year-old children with early treated phenylketonuria. J Pediatr 112:403-408
70. Smith I, Beasley MG, Ades AE (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65:472-478
71. Smith I, Beasley MG, Ades AE (1991) Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 65:311-316
72. Sonneville LMJ de, Schmidt E, Michel U, Batzler U (1990) Preliminary neuropsychological test results of the German phenylketonuria study. Eur J Pediatr 149 [Suppl 1]:S39-S44
73. Stellungnahme der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS) zur diätetischen Behandlung der Phenylketonurie (1990). Monatsschr Kinderheilkd 138:636
74. Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC, Kendall B, Lees AJ (1990) Neurological deterioration in young adults with phenylketonuria. Lancet 336:602-605
75. Treacy E, Pitt JJ, Seller K, Thompson GN, Ramus S, Cotton RGH (1996) In vivo disposal of phenylalanine in phenylketonuria: a study of two siblings. J Inherit Metab Dis 19:595-602
76. Trefz FK, Burgard P, König Th, Goebel-Schreiner B, Lichter-Konecki U, Konecki D, Schmidt E, Schmidt H, Bickel H (1993) Genotype-phenotype correlations in phenylketonuria. Clin Chim Acta 217:15-21
77. Trefz FK, Ullrich K, Cipcic-Schmidt S, Fünders-Bücker B, Teeffelen-Heithoff A van, Przyrembel H (1995) Prophylaxe und Behandlung der maternalen Phenylketonurie (MPKU) Stellungnahme der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen. Monatsschr Kinderheilkd 143:898-899
78. Tyfield LA, Zschocke J, Stephenson A, Cockburn F, Harvie A, Bidwell JL, Wood NA, Hunt LP (1995) Discordant phenylketonuria phenotypes in one family: the relationship between genotype and clinical outcome is a function of multiple effects. J Med Genet 32:867-870
79. Ullrich K, Möller H, Weglage J, Schuierer G, Bick U, Ludolph A, Hahn-Ullrich H, Fünders B, Koch HG (1994) White matter abnormalities in phenylketonuria: results of magnetic resonance measurements. Acta Pdiatr 83 [Suppl 407]:78-82
80. Van Spronsen FJ, van Rijn M, van Dijk T, Smit GPA, Reijngoud DJ, Berger R, Heymans HSA (1993) Plasma phenylalanine and tyrosine response to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sampling timing. Pediatrics 92:570-573
81. Villasana D, Butler IJ, Williams JC, Roongta SM (1989) Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 12:451-457
82. Waisbren SE, Brown MJ, Sonneville LMJ de, Levy HL (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr 83 [Suppl 407]:98-103
83. Weglage J, Fünders B, Wilken B, Schubert D, Schmidt E, Burgard P, Ullrich K (1992) Psychological findings in adolescents with phenylketonuria. Eur J Pediatr, 151:522-525
84. Weglage J, Fünders B, Wilken B, Schubert D, Ullrich K (1993) School performance and intellectual outcome in adolescents with phenylketonuria. Acta Paediatr 81:582-586
85. Weglage J, Rupp A, Schmidt E (1994) Personality characteristics in patients with phenylketonuria treated early. Pediatr Res 35:611-613
86. Weglage J, Pietsch M, Fünders B, Koch HG, Ullrich K (1996) Deficits in selective and sustained attention processes in early treated children with phenylketonuria - result of impaired frontal lobe functions? Eur J Pediatr 155:200-204
87. Weglage J, Schmidt E, Fünders B, Pietsch B, Ullrich K (1996) Sustained attention in untreated non-PKU-hyperphenylalaninemia. J Clin Exp Neuropsychol 18:343-348
88. Weglage J, Ullrich K, Pietsch M, Fünders B, Zaß R, Koch HG (1996) Untreated non-Phenylketonuric-hyperphenylalaninemia: intellectual and neurological outcome. Eur J Pediatr 155 [Suppl 1]:S26-S28
89. Welsh MC, Pennington BF, Oznoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev 61:1697-1713
90. Yannicelli S, Ryan A (1995) Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: a national survey. J Inherit Metab Dis 18:131-134
91. Zetterström R (1995) Editorial comment on phenylketonuria Acta Pediatr 84:716-718